Prab at 21:02, 16 March 2025

2025-03-16T21:02:19Z

← Older revision		Revision as of 21:02, 16 March 2025
Line 26:		Line 26:

	{{Medicine-stub}}		{{Medicine-stub}}
	~~{{No image}}~~
	<gallery>		<gallery>
	File:Hexarelin structure.png\|Examorelin		File:Hexarelin structure.png\|Examorelin
	</gallery>		</gallery>

Prab: CSV import

2025-02-20T01:44:16Z

CSV import

← Older revision		Revision as of 01:44, 20 February 2025
Line 27:		Line 27:
	{{Medicine-stub}}		{{Medicine-stub}}
	{{No image}}		{{No image}}
			<gallery>
			File:Hexarelin structure.png\|Examorelin
			</gallery>

Prab: CSV import

2025-02-10T16:59:51Z

CSV import

← Older revision		Revision as of 16:59, 10 February 2025
Line 26:		Line 26:

	{{Medicine-stub}}		{{Medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-22T09:14:21Z

CSV import

New page

'''Examorelin''', also known by its developmental code name '''EP-23905''', is a synthetic peptide that acts as a [[Growth Hormone Secretagogue Receptor|growth hormone secretagogue]] (GHS). It is part of a class of drugs known as [[ghrelin]] mimetics, which mimic the action of the endogenous hormone ghrelin in the body. Ghrelin is often referred to as the "hunger hormone" because it stimulates appetite, but it also plays a significant role in the regulation of [[Growth Hormone (GH)|growth hormone (GH)]] secretion.

==Mechanism of Action==
Examorelin binds to and activates the [[Growth Hormone Secretagogue Receptor 1a (GHS-R1a)]], which is located in the pituitary gland and hypothalamus. This activation leads to an increase in the secretion of growth hormone by the pituitary gland. The increase in GH can contribute to the growth of lean body mass, improvement in lipid profile, and may enhance the healing of injuries.

==Clinical Uses==
While Examorelin has been extensively studied in clinical trials for its potential applications, it is not currently approved for medical use in any country. Research has focused on its potential for treating [[Growth Hormone Deficiency|growth hormone deficiency]] in both children and adults, as well as its possible benefits in improving physical performance and body composition in athletes and the elderly.

==Side Effects==
As with other GH secretagogues, the use of Examorelin can lead to side effects similar to those of elevated GH levels, such as [[Edema|fluid retention]], [[Carpal Tunnel Syndrome|carpal tunnel syndrome]], and [[Hyperglycemia|increased blood sugar levels]]. However, the severity and incidence of these side effects can vary among individuals.

==Research and Development==
The development of Examorelin as a therapeutic agent has been part of the broader search for effective GH secretagogues that can serve as alternatives to direct GH administration, which is associated with several drawbacks, including the risk of developing antibodies against GH. Despite its promising profile, the development of Examorelin for clinical use has been limited, and it remains a compound of interest primarily in research settings.

==See Also==
* [[Ghrelin]]
* [[Growth Hormone Secretagogue]]
* [[Growth Hormone Treatment]]

==References==
<references/>

[[Category:Peptides]]
[[Category:Growth hormones]]
[[Category:Endocrinology]]

{{Medicine-stub}}

Examorelin - Revision history

Prab at 21:02, 16 March 2025

Prab: CSV import

Prab: CSV import

Prab: CSV import